Clinical spectrum, risk factors and outcomes of paradoxical tuberculosis immune reconstitution inflammatory syndrome among patients with tuberculosis-HIV coinfection commencing antiretroviral therapy

W. Worodria; J. Menten; Marguerite Massinga Loembé; D. Mazakpwe; D. Bagenda; O. Koole; H. Mayanja-Kizza; L. Kestens; R. Mugerwa; P. Reiss; R. Colebunders

doi:10.3851/IMP2108

Clinical spectrum, risk factors and outcomes of paradoxical tuberculosis immune reconstitution inflammatory syndrome among patients with tuberculosis-HIV coinfection commencing antiretroviral therapy

W. Worodria, J. Menten, Marguerite Massinga Loembé, D. Mazakpwe, D. Bagenda, O. Koole, H. Mayanja-Kizza, L. Kestens, R. Mugerwa, P. Reiss, R. Colebunders

Clinical Trial Centre

Research output: Contribution to journal › A1: Web of Science-article › peer-review

Original language	English
Journal	Antiviral Therapy
Volume	17
Issue number	5
Pages (from-to)	841-848
Number of pages	8
ISSN	1359-6535
DOIs	https://doi.org/10.3851/IMP2108
Publication status	Published - 2012

Keywords

Viral diseases
HIV
AIDS
Co-infections
Bacterial diseases
Tuberculosis
Mycobacterium tuberculosis
Immune reconstitution inflammatory syndrome (IRIS)
IRIS
HAART
Antiretrovirals
Risk factors
Treatment outcome
Extra-pulmonary
Clinical manifestations

Access to Document

10.3851/IMP2108

Cite this

Worodria, W., Menten, J., Massinga Loembé, M., Mazakpwe, D., Bagenda, D., Koole, O., Mayanja-Kizza, H., Kestens, L., Mugerwa, R., Reiss, P., & Colebunders, R. (2012). Clinical spectrum, risk factors and outcomes of paradoxical tuberculosis immune reconstitution inflammatory syndrome among patients with tuberculosis-HIV coinfection commencing antiretroviral therapy. Antiviral Therapy, 17(5), 841-848. https://doi.org/10.3851/IMP2108

@article{80b2f87e60e341bf88fc4c97d24c4d71,

title = "Clinical spectrum, risk factors and outcomes of paradoxical tuberculosis immune reconstitution inflammatory syndrome among patients with tuberculosis-HIV coinfection commencing antiretroviral therapy",

keywords = "Viral diseases, HIV, AIDS, Co-infections, Bacterial diseases, Tuberculosis, Mycobacterium tuberculosis, Immune reconstitution inflammatory syndrome (IRIS), IRIS, HAART, Antiretrovirals, Risk factors, Treatment outcome, Extra-pulmonary, Clinical manifestations",

author = "W. Worodria and J. Menten and {Massinga Loemb{\'e}}, Marguerite and D. Mazakpwe and D. Bagenda and O. Koole and H. Mayanja-Kizza and L. Kestens and R. Mugerwa and P. Reiss and R. Colebunders",

note = "NPP; ITG-C2A; ITG-B3B; ITG-C6A; ITG-B8A; ITG-CLA; MULTI; DCS; U-CTU; U-HIVCLI; DBM; U-IMMUN; JIF; DOI; DSPACE",

year = "2012",

doi = "10.3851/IMP2108",

language = "English",

volume = "17",

pages = "841--848",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "International Medical Press Ltd",

number = "5",

}

Worodria, W, Menten, J, Massinga Loembé, M, Mazakpwe, D, Bagenda, D, Koole, O, Mayanja-Kizza, H, Kestens, L, Mugerwa, R, Reiss, P & Colebunders, R 2012, 'Clinical spectrum, risk factors and outcomes of paradoxical tuberculosis immune reconstitution inflammatory syndrome among patients with tuberculosis-HIV coinfection commencing antiretroviral therapy', Antiviral Therapy, vol. 17, no. 5, pp. 841-848. https://doi.org/10.3851/IMP2108

Clinical spectrum, risk factors and outcomes of paradoxical tuberculosis immune reconstitution inflammatory syndrome among patients with tuberculosis-HIV coinfection commencing antiretroviral therapy. / Worodria, W.; Menten, J.; Massinga Loembé, Marguerite et al.
In: Antiviral Therapy, Vol. 17, No. 5, 2012, p. 841-848.

Research output: Contribution to journal › A1: Web of Science-article › peer-review

TY - JOUR

T1 - Clinical spectrum, risk factors and outcomes of paradoxical tuberculosis immune reconstitution inflammatory syndrome among patients with tuberculosis-HIV coinfection commencing antiretroviral therapy

AU - Worodria, W.

AU - Menten, J.

AU - Massinga Loembé, Marguerite

AU - Mazakpwe, D.

AU - Bagenda, D.

AU - Koole, O.

AU - Mayanja-Kizza, H.

AU - Kestens, L.

AU - Mugerwa, R.

AU - Reiss, P.

AU - Colebunders, R.

N1 - NPP; ITG-C2A; ITG-B3B; ITG-C6A; ITG-B8A; ITG-CLA; MULTI; DCS; U-CTU; U-HIVCLI; DBM; U-IMMUN; JIF; DOI; DSPACE

PY - 2012

Y1 - 2012

KW - Viral diseases

KW - HIV

KW - AIDS

KW - Co-infections

KW - Bacterial diseases

KW - Tuberculosis

KW - Mycobacterium tuberculosis

KW - Immune reconstitution inflammatory syndrome (IRIS)

KW - IRIS

KW - HAART

KW - Antiretrovirals

KW - Risk factors

KW - Treatment outcome

KW - Extra-pulmonary

KW - Clinical manifestations

U2 - 10.3851/IMP2108

DO - 10.3851/IMP2108

M3 - A1: Web of Science-article

C2 - 22543224

SN - 1359-6535

VL - 17

SP - 841

EP - 848

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - 5

ER -